TruTag provides instant, on-product authentication throughout the supply chain and across industries
SANTA CLARA, California, July 5, 2017 /PRNewswire/ -- Based on its recent analysis of the product authentication market, Frost & Sullivan recognizes TruTag Technologies, Inc. (TruTag) with the 2017 North American Frost & Sullivan Award for Technology Innovation. TruTag's
Photo - https://mma.prnewswire.com/media/530364/TruTag_Technologies_Award.jpg
Silicon dioxide is affirmed by the U.S. Food and Drug Administration (FDA) as Generally Recognized as Safe (GRAS), making it fit for human consumption. The edibility and convertibility of TruTags enhance their value in the healthcare industry, as they can be used directly on pharmaceuticals. Researchers are exploring the use of silicon dioxide particles in groundbreaking applications such as the controlled release of drugs. Porous silicon dioxide particles are considered ideal for in-vivo drug delivery because they are both biocompatible and biodegradable, and the particle porosity may be precision-made for storage and delivery of the drug. They are gaining traction in the chemicals industry as well, as their ability to withstand temperatures of nearly 1,000 degrees Celsius allows them to be mixed into a coating or polymer/plastic.
TruTag etches silicon dioxide particles in batches to create unique combinations of nano-pores of customizable shape and depth for each customer and industry. The nano-pores reflect light at discrete, selected wavelengths that are authenticated by the company's portable readers; therefore, each microtag possesses an optical signature that is unique, identifiable, and extremely secure.
"The microtags' spectral codes provide information at the product level as well as the country, batch, and distributor levels," said Frost & Sullivan's Senior Research Analyst Aniruddha Roy. "With the help of the tags, customers can collect information like dosage, manufacturing site, authorized distribution channel, lot number, drug package insert, and related safety information."
TruTag's technology is highly scalable and can meet diverse customer requirements. The company's new manufacturing plant has high-volume, automated production capabilities that have increased capacity more than 50-fold in recent years This production facility, which manufactures microtags for the pharmaceutical and food industries, is current good manufacturing practices (cGMP)-compliant and is the world's largest cGMP precision nano-porous silica production plant.
"TruTag is a vertically integrated company that has complete control over raw material selection, particularly the quality and purity of the materials, from the product development stage through deployment," noted Roy. "The company invests heavily in R&D and fosters close relations with various end-user industries. It signed a strategic partnership with PT Carsurin, an Indonesia-based inspection and testing company, for enhancing its supply chain security offerings. TruTag also recently entered into a strategic relationship with IRIS Corporation Bhd, a Malaysia-based provider of digital identity and smart ID solutions, for leveraging TruTag's technology in a variety of products. In another significant move, TruTag has partnered with US-based Spinnaker Biosciences to supply precisely engineered, nano-porous silica particles for sustained-release drug delivery."
TruTag has acquired new customers and retained existing ones by virtue of its unique, out-of-the-box technology. Its steadfast commitment to technology innovation has helped it stay ahead of competition, drive future business value, and raise the bar for innovation in the product authentication market.
Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend towards innovation, its relevance to the industry, and the positive impact on brand perception.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About TruTag Technologies, Inc.
TruTag Technologies, Inc. is a leading security and technology solutions provider serving businesses and governments around the world. TruTag has the most advanced precision-fabricated, cGMP nano-porous silica manufacturing operation in the world for a variety of applications and security solutions, including product identity for food, medicine, secure labels and documents. The company's highly-specialized nano-porous silica particles extend to precision drug delivery systems for the biopharmaceutical industry. TruTag's nano-fabrication technology platform is complemented by its advanced hyperspectral imaging solutions, which can be applied to a broad array of market applications from medical diagnostics to machine vision.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.
Frost & SullivanSamantha ParkP: 210.247.2426F: 210.348.1003E: email@example.com
TruTag TechnologiesPaula PageP: 650.279.3881E: firstname.lastname@example.org
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All